Skip to content
2000
Volume 23, Issue 1
  • ISSN: 1871-5273
  • E-ISSN: 1996-3181

Abstract

Embelin (EMB) (2,5-Dihydroxy-3-undecyl-1,4-benzoquinone) is a natural benzoquinone extracted mainly from (ER) and appear as vivid orange dots beneath the fruit's pericarp. It is being used to treat various diseases since ancient times in India. It has been ascribed as one of the 32 ayurvedic drugs of national importance in the National Medicinal Plant Board set up by the Government of India under the Ministry of Indian System of Medicine and Homeopathy. Embelin prevents neuronal oxidative damage by decreasing the peroxidation of lipids. Along with having antioxidant properties, it also prevents the production of amyloid-protein-related fibrils and blocks the progression of inflammatory cascades. Due to embelin's ability to cross the blood-brain barrier, its neuroprotective effects have been studied in the past using models of neuronal disorders such as convulsion and epilepsy, Alzheimer's disease, anxiety and depression, traumatic brain injury, cerebral ischemia, Huntington's disease, and multiple sclerosis. In addition to its neuroprotective effects, its role as an antitubercular, anti-cancer, antioxidant, astringent, anti-inflammatory, anti-bacterial, contraceptive, carminative, diuretic, and anthelmintic agent has also been studied. With docking studies and recent advancements in formulations of embelin including polyethylene and embelin micelles and embelin noisome preparations, embelin can prove to be a promising compound for its therapeutic actions in a wide range of diseases and disorders. The findings of docking studies suggest the binding ability of embelin to be similar to the standard drug in their respective disorders. In this review and docking analysis, we bring an outline of scientific evidence concerning the neuroprotective actions of embelin, still, further research is required for its prospective as a chief compound in clinical approaches.

Loading

Article metrics loading...

/content/journals/cnsnddt/10.2174/1871527322666230119100053
2024-01-01
2025-01-07
Loading full text...

Full text loading...

References

  1. SouraviK. RajasekharanP.E. Ethnopharmacological Uses of Embelia ribes Burm. F. - A Review.IOSR J. Pharm. Biol. Sci.201493233010.9790/3008‑09332330
    [Google Scholar]
  2. DurgS. VeerapurV.P. NeelimaS. DhaddeS.B. Antidiabetic activity of Embelia ribes, embelin and its derivatives: A systematic review and meta-analysis.Biomed. Pharmacother.20178619520410.1016/j.biopha.2016.12.00127984799
    [Google Scholar]
  3. PoojariR. Embelin – a drug of antiquity: shifting the paradigm towards modern medicine.2014233427-44
  4. BashaN.J. BasavarajaiahS.M. BaskaranS. KumarP. A comprehensive insight on the biological potential of embelin and its derivatives. In:Natural Product Research.Taylor & Francis2021
    [Google Scholar]
  5. NagamaniV. RaniA.S. SatyakalaM. ChG.N.V. Reddy rashekar. High performance liquid chromatography (HPLC) analysis of embelin in different samples of Embelis ribes Burm. f. - a threatened medicinal plant of India.J. Med. Plants Res.201372417611767
    [Google Scholar]
  6. NuthakkiVK SharmaA KumarA BharateSB Identification of embelin, a 3‐undecyl‐1,4‐benzoquinone from Embelia ribes as a multitargeted anti‐Alzheimer agent.Drug Dev Res2019805ddr.2154410.1002/ddr.2154431050027
    [Google Scholar]
  7. HarishG.U. DanapurV. JainR. PatellV.M. Endangered Medicinal Plant Embelia ribes Burm.f.- A Review.Pharmacogn. J.201242761910.5530/pj.2012.27.2
    [Google Scholar]
  8. FeresinG.E. TapiaA. SortinoM. Bioactive alkyl phenols and embelin from Oxalis erythrorhiza.J. Ethnopharmacol.2003882-324124710.1016/S0378‑8741(03)00258‑712963150
    [Google Scholar]
  9. PodolakI. GalantyA. JaneczkoZ. Cytotoxic activity of embelin from Lysimachia punctata.Fitoterapia2005763-433333510.1016/j.fitote.2005.02.00615890461
    [Google Scholar]
  10. PandyaV PatelJ TechnolDP-D Formulation and optimization of nanosuspensions for enhancing simvastatin dissolution using central composite design. dissolutiontechcom201118340-5
  11. SinghB. GuruS.K. SharmaR. Synthesis and anti-proliferative activities of new derivatives of embelin.Bioorg. Med. Chem. Lett.201424204865487010.1016/j.bmcl.2014.08.05225240254
    [Google Scholar]
  12. FanY. ZhaoL. HuangX. Pharmacokinetic and bioavailability studies of α-viniferin after intravenous and oral administration to rats.J. Pharm. Biomed. Anal.202018811337610.1016/j.jpba.2020.11337632502955
    [Google Scholar]
  13. LathaC. Microwave-assisted extraction of embelin from Embelia ribes.Biotechnol. Lett.200729231932210.1007/s10529‑006‑9243‑z17124632
    [Google Scholar]
  14. LuH. WangJ. WangY. QiaoL. ZhouY. Embelin and its role in chronic diseases.Adv. Exp. Med. Biol.201692839741810.1007/978‑3‑319‑41334‑1_1627671825
    [Google Scholar]
  15. ParmarK. PatelJ. ShethN. Formulation and optimization of Embelin nanosuspensions using central composite design for dissolution enhancement.J. Drug Deliv. Sci. Technol.2015291710.1016/j.jddst.2015.05.011
    [Google Scholar]
  16. PengM. HuangB. ZhangQ. Embelin inhibits pancreatic cancer progression by directly inducing cancer cell apoptosis and indirectly restricting IL-6 associated inflammatory and immune suppressive cells11These authors contributed equally to this work.Cancer Lett.2014354240741610.1016/j.canlet.2014.08.01125128650
    [Google Scholar]
  17. PathanR.A. BhandariU. Preparation & characterization of embelin–phospholipid complex as effective drug delivery tool.J. Incl. Phenom. Macrocycl. Chem.2011691-213914710.1007/s10847‑010‑9824‑2
    [Google Scholar]
  18. BhuvanendranS. BakarS.N.S. KumariY. OthmanI. ShaikhM.F. HassanZ. Embelin Improves the Spatial Memory and Hippocampal Long-Term Potentiation in a Rat Model of Chronic Cerebral Hypoperfusion.Sci. Rep.2019911450710.1038/s41598‑019‑50954‑y31601902
    [Google Scholar]
  19. FuX. PangX. QiH. ChenS. LiY. TanW. XIAP inhibitor Embelin inhibits bladder cancer survival and invasion in vitro.Clin. Transl. Oncol.201618327728210.1007/s12094‑015‑1363‑226209051
    [Google Scholar]
  20. RhodusN.L. ChengB. MyersS. MillerL. HoV. OndreyF. The feasibility of monitoring NF-κB associated cytokines: TNF-α IL-1α IL-6, and IL-8 in whole saliva for the malignant transformation of oral lichen planus.Mol. Carcinog.2005442778210.1002/mc.2011316075467
    [Google Scholar]
  21. PodolakI. Strzałka M. Qualitative and quantitative lc profile of embelin and rapanone in selected lysimachia species.Chromatogr200867547147510.1365/s10337‑007‑0511‑4
    [Google Scholar]
  22. PrasadS.B. Embelin: A potential Benzoquinone.International Journal of Current Pharmaceutical Review and Research20178310.25258/ijcprr.v8i03.9204
    [Google Scholar]
  23. SreepriyaM. BaliG. Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats.Fitoterapia200576654955510.1016/j.fitote.2005.04.01416009505
    [Google Scholar]
  24. LiZ. ChenS.J. YuX.A. LiJ. GaoX.M. HeJ. Pharmacokinetic and bioavailability studies of embelin after intravenous and oral administration to rats.Evidence-based Complement Altern Med201910.1155/2019/9682495
    [Google Scholar]
  25. KundapU.P. BhuvanendranS. KumariY. OthmanI. ShaikhM.F. Plant derived phytocompound, embelin in CNS disorders: A systematic review.Front. Pharmacol.201787610.3389/fphar.2017.0007628289385
    [Google Scholar]
  26. BhuvanendranS. HanapiN.A. AhemadN. OthmanI. YusofS.R. ShaikhM.F. Embelin, a potent molecule for Alzheimer’s disease: Embelin, a potent molecule for Alzheimer’s disease A proof of concept from blood-brain barrier permeability, acetylcholinesterase inhibition and molecular docking studies Embelin.Front. Neurosci.20191349510.3389/fnins.2019.0049531156375
    [Google Scholar]
  27. SiegelC. LiJ. LiuF. BenashskiS.E. McCulloughL.D. miR-23a regulation of X-linked inhibitor of apoptosis (XIAP) contributes to sex differences in the response to cerebral ischemia.Proc. Natl. Acad. Sci. USA201110828116621166710.1073/pnas.110263510821709246
    [Google Scholar]
  28. MahendranS. ThippeswamyB.S. VeerapurV.P. BadamiS. Anticonvulsant activity of embelin isolated from Embelia ribes.Phytomedicine2011182-318618810.1016/j.phymed.2010.04.00220605710
    [Google Scholar]
  29. K G. GABA and epilepsy: basic concepts from preclinical research.Epilepsia199233Suppl. 5S3S12
    [Google Scholar]
  30. GajcyK. Lochyński S, Librowski T. A role of GABA analogues in the treatment of neurological diseases.Curr. Med. Chem.201017222338234710.2174/09298671079169854920491640
    [Google Scholar]
  31. GuptaG. KazmiI. AfzalM. UpadhyayG. SinghR. HabtemariamS. Antidepressant-like activity of Embelin isolated from Embelia ribes. herbalanalysiscouk 2013; 2013(1): 87-95. Available from: herbalanalysis.co.uk
  32. AfzalM. GuptaG. KazmiI. Evaluation of anxiolytic activity of embelin isolated from Embelia ribes.Biomed. Aging Pathol.201222454710.1016/j.biomag.2012.03.003
    [Google Scholar]
  33. MöhlerH. The GABA system in anxiety and depression and its therapeutic potential.Neuropharmacology2012621425310.1016/j.neuropharm.2011.08.04021889518
    [Google Scholar]
  34. LobatoKR CardosoCC BinfaréRW α-Tocopherol administration produces an antidepressant-like effect in predictive animal models of depression.Behav. Brain Res.2010209224925910.1016/j.bbr.2010.02.00220144659
    [Google Scholar]
  35. KlumpersU.M.H. VeltmanD.J. DrentM.L. Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results.Eur. J. Nucl. Med. Mol. Imaging201037356557410.1007/s00259‑009‑1292‑919890631
    [Google Scholar]
  36. GhoseS. WinterM.K. McCarsonK.E. TammingaC.A. EnnaS.J. The GABAB receptor as a target for antidepressant drug action.Br. J. Pharmacol.2011162111710.1111/j.1476‑5381.2010.01004.x20735410
    [Google Scholar]
  37. WangB. ChenX. ZhouT. WangX. Antidepressant-like effects of embelin and its possible mechanisms of action in chronic unpredictable stress-induced mice.Neurol. Res.201840811110.1080/01616412.2018.146070529681219
    [Google Scholar]
  38. HolthoffV.A. KoeppeR.A. FreyK.A. Positron emission tomography measures of benzodiazepine receptors in Huntington’s disease.Ann. Neurol.1993341768110.1002/ana.4103401148390806
    [Google Scholar]
  39. DhaddeS.B. NagakannanP. RoopeshM. Effect of embelin against 3-nitropropionic acid-induced Huntington’s disease in rats.Biomed. Pharmacother.201677525810.1016/j.biopha.2015.11.00926796265
    [Google Scholar]
  40. LassmannH. Multiple Sclerosis Pathology20181-1510.1101/cshperspect.a028936
    [Google Scholar]
  41. YanJ. GreerJ. NF-kappa B, a potential therapeutic target for the treatment of multiple sclerosis.CNS Neurol. Disord. Drug Targets20087653655710.2174/18715270878712294119128210
    [Google Scholar]
  42. HuR. WuB. ZhangG.J. Effect of Embelin on proliferation, differentiation and aopotosis of HL-60 cells.Zhonghua Xue Ye Xue Za Zhi201031744244521122396
    [Google Scholar]
  43. XueZ GeZ ZhangK SunR YangJ Embelin suppresses dendritic cell functions and limits autoimmune encephalomyelitis through the TGF-β/β-catenin and STAT3 signaling pathways.Springer20134921087-101
    [Google Scholar]
  44. BarbalhoC.A. Nunes-de-SouzaR.L. Canto-de-SouzaA. Similar anxiolytic-like effects following intra-amygdala infusions of benzodiazepine receptor agonist and antagonist: Evidence for the release of an endogenous benzodiazepine inverse agonist in mice exposed to elevated plus-maze test.Brain Res.20091267657610.1016/j.brainres.2009.02.04219268657
    [Google Scholar]
  45. HodaU. JainS. SamimM. JainG.K. AgarwalN.B. Embelin ameliorates cognitive dysfunction and progression of kindling in pentylenetetrazol-induced kindling in mice by attenuating brain inflammation.Epilepsy Behav.202111610778810.1016/j.yebeh.2021.10778833581600
    [Google Scholar]
  46. DurgS B NK, Vandal R, et al. Antipsychotic activity of embelin isolated from Embelia ribes: A preliminary study.Biomed. Pharmacother.20179032833110.1016/j.biopha.2017.03.08528376400
    [Google Scholar]
  47. ShaikhA. DhaddeS.B. DurgS. Effect of embelin against lipopolysaccharide-induced sickness behaviour in mice.Phytother. Res.201630581582210.1002/ptr.558526890475
    [Google Scholar]
  48. PatelR SciencePG-O Effect of embelin in middle cerebral artery occlusioninduced focal cerebral ischemia in rats.ejmoamscom201432135-9
    [Google Scholar]
  49. PlesnilaN. von BaumgartenL. RetiounskaiaM. Delayed neuronal death after brain trauma involves p53-dependent inhibition of NF-κB transcriptional activity.Cell Death Differ.20071481529154110.1038/sj.cdd.440215917464322
    [Google Scholar]
  50. ThippeswamyB.S. NagakannanP. ShivasharanB.D. MahendranS. VeerapurV.P. BadamiS. Protective effect of embelin from Embelia ribes Burm. against transient global ischemia-induced brain damage in rats.Neurotox. Res.201120437938610.1007/s12640‑011‑9258‑721751076
    [Google Scholar]
  51. AroraR. DeshmukhR. Embelin attenuates intracerebroventricular Streptozotocin-Induced behavioral, biochemical, and neurochemical abnormalities in rats.Mol. Neurobiol.20175496670668010.1007/s12035‑016‑0182‑y27744573
    [Google Scholar]
  52. SainiP. LakshmayyaL. BishtV.S. Anti-Alzheimer activity of isolated karanjin from Pongamia pinnata (L.) pierre and embelin from Embelia ribes Burm.f.Ayu2017381-27681[An Int Q J Res Ayurveda29861598
    [Google Scholar]
  53. MaesM. BerkM. GoehlerL. Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways.BMC Med.20121016610.1186/1741‑7015‑10‑6622747645
    [Google Scholar]
  54. MacDermottR.P. SandersonI.R. ReineckerH.C. The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn’s disease.Inflamm. Bowel Dis.199841546710.1097/00054725‑199802000‑000099552229
    [Google Scholar]
  55. SteinmanL. Elaborate interactions between the immune and nervous systems.Nat. Immunol.20045657558110.1038/ni107815164017
    [Google Scholar]
  56. TrottO. OlsonA.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.J. Comput. Chem.201031245546119499576
    [Google Scholar]
  57. OlsenA.B. HetzR.A. XueH. Effects of traumatic brain injury on intestinal contractility.Neurogastroenterol. Motil.2013257593e46310.1111/nmo.1212123551971
    [Google Scholar]
  58. StephensonD. YinT. SmalstigE.B. Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia.J. Cereb. Blood Flow Metab.200020359260310.1097/00004647‑200003000‑0001710724123
    [Google Scholar]
  59. WellerJ. BudsonA. Current understanding of Alzheimer’s disease diagnosis and treatment. In: F1000Research.20187
  60. WangY. Santa-CruzK. DeCarliC. JohnsonJ.A. NAD(P)H: Quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Alzheimer’s disease.Neurobiol. Aging200021452553110.1016/S0197‑4580(00)00114‑710924765
    [Google Scholar]
/content/journals/cnsnddt/10.2174/1871527322666230119100053
Loading
/content/journals/cnsnddt/10.2174/1871527322666230119100053
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test